THE NEAR FUTURE WITH CGI
CGI will provide to commercial companies variant classification and reclassification services faster, more accurately, and at lower-cost than they can do on their own. As a 501(c)(3) non-profit company, CGI prioritizes transformative services to ultimately benefit patients, rather than maximizing profits. At the same time, CGI is operated with the focus and efficiency of a for-profit company by experienced, industry professionals. CGI will succeed by transparently innovating and achieving an economy of scale that few, if any, companies can achieve in isolation or in limited partnerships. CGI’s greatest global impact will be attained through serving the companies, hospital systems, and clinics that run genetic tests for millions of patients and consumers each year.
Ultimately, CGI aims to improve global healthcare in the genetics sector by increasing accuracy of genetic testing while driving down costs, allowing greater access to quality genetics.